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Summary Background and aims: We showed that continuing education can be
embedded into routine diabetes care by seeing patients in small groups rather than
individually. Group care was cost-effective in improving quality of life, knowledge
of diabetes, health behaviours and clinical outcomes in people with type 2
diabetes. The aim of this study was to verify if group care can also be applied to
type 1 diabetes.
Methods and results: Randomized, controlled clinical trial comparing 31 patients
managed by group care with 31 managed by traditional one-to-one care. A syllabus
was built and later remodulated with the patients in a series of focus-group
meetings. The primary end-point was changes in quality of life. Secondary end-
points were: knowledge of diabetes, health behaviours, HbA1c and circulating
lipids. Differential costs to the Italian National Health System and to the patients
were also calculated.
After 3 years, quality of life improved among patients on group care, along
with knowledge and health behaviours (p! 0.001, all). Knowledge added its
effects to those of group care by independently influencing behaviours (pZ 0.004)
while quality of life changed independently of either (p! 0.001). Among
controls, quality of life worsened (p! 0.001) whereas knowledge and behaviours
remained unchanged. HDL cholesterol increased among patients on group care
(pZ 0.027) and total cholesterol decreased in the controls (p! 0.05). HbA1c
Abbreviations: CdR, health behaviours (Condotte di Riferimento); DQOL, diabetes quality of life; GISED, Italian Study Group on
Diabetes Education; INHS, Italian National Health System.
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294 M. Trento et al.decreased, though not significantly, in both. Direct costs for group and one-to-one
care were V 933.19 and V 697.10 per patient, respectively, giving a cost-
effectiveness ratio of V 19.42 spent per point gained in the quality of life scale.
Conclusions: Group care is applicable and also cost-effective in type 1 diabetes. It
improves quality of life, knowledge and behaviours. Future programme adjust-
ments should strive to impact more on metabolic control.
ª 2005 Elsevier B.V. All rights reserved.Introduction
Type 1 diabetes (T1DM) is a chronic illness that
requires continuing professional care combined
with patient self-care to prevent or delay acute
and long-term complications [1e5]. The primary
goals of treatment are to maintain blood glucose
levels and quality of life as close as possible to those
of non-diabetic people [6]. Intensified insulin ther-
apy improves metabolic control and reduces the
incidence of complications [7,8] but, to fully ben-
efit from it, patients need knowledge and skills that
enable them to make informed choices to facilitate
appropriate behavioural changes [1,9,10]. Such
benefits can only be achieved if patients are offered
structured and comprehensiveeducation integrated
in diabetes care. Indeed, patient-centred ap-
proaches have demonstrated positive outcomes for
health behaviours and metabolic control [11,12].
Usually, patient education is offered as an
adjunct to clinical care, within routine one-to-one
visits or as self-contained structured courses for
individuals or groups [4,5,13,14]. This requires
allocation of additional time and resources that
are scarce in most clinics. We have shown that
continuing education can be embedded into the
routine care of non-insulin-treated type 2 diabetes
(T2DM) if patients are regularly seen in small groups
rather than individually. Group carewas found to be
a feasible, cost-effective approach to improve
quality of life, knowledge of diabetes and health
behaviours while achieving sustained weight re-
duction, stabilization of HbA1c and increased HDL
cholesterol over 5 years [15e17].
This study was aimed at verifying if group care
can also be applied to the routine care of T1DM. In
particular, we tested if, also in T1DM, group care
would improve patients’ quality of life, knowledge
of diabetes, health behaviours and metabolic
control.
Methods
Sixty-twopeoplewithT1DMwere randomly selected
by random table numbers by one member ofthe team from the patient population in our clinic.
Inclusion criteria were: onset before age 30 and
insulin treatment started within 1 year of diagnosis;
age! 70 and at least 1 year previous attendance in
our clinic. All patients were on 4-daily insulin
injections and practiced self-monitoring of blood
glucose. Seven patients on group care and 7 controls
were on LisPro insulin. None was on hypolipidaemic
agents at the time of study. None refused to
participate and all gave their informed consent to
the study, which conformed with the principles of
the Helsinki Declaration. After randomization by
random table numbers, 31 patients were assigned
to 5 groups of 6e7 patients each, while 31 control
subjects continued with traditional individual con-
sultations. Their baseline characteristics are listed
in Table 1. In spite of randomization, control
patients had different schooling levels (p! 0.05)
and higher HbA1c levels at baseline (pZ 0.015).
Education programme
Four focus groups [18e20] were run with 5/6
patients each, not necessarily including those
who participated in the study, to explore their
expectations, needs, knowledge and beliefs on
diabetes [21]. These sessions were audiotaped,
transcribed verbatim and analysed to establish the
educational goals [18]. The patients wished to
learn more on: slow-, intermediate-, fast-, and
very fast-acting insulins; insulin injection techni-
ques, areas and rotation; hypoglycaemia and
hyperglycaemia; what to do during intercurrent
illnesses; glycated haemoglobin, fructosamine and
glycosuria; complications: blindness and kidney
failure; what to do in the occasion of regular
check-ups for driving licence renewal and occupa-
tional medicine; nutrition and physical exercise.
A 9-session programme was developed according
to a systemic education approach [22] to address
these topics.
After these 9 sessions, the programme was re-
assessed in a second round of focus groups, this
time involving all the patients who had received
group care. Expectations and requests were again
collected and re-analysed, leading to a redefinition
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Group care Controls
No. 31 31
Sex
M 19 (61.3%) 18 (58.1%) N.S.
F 12 (38.7%) 13 (41.9%)
Age (median and interquartile range) 27 (23e33) 31 (25e43) N.S.
Schoolinga
P 2 (6.5%) 0 (0.0%) p! 0.05
M 3 (9.7%) 11 (35.5%)
H 25 (80.6%) 20 (64.5%)
U 1 (3.2%) 0 (0.0%)
Occupationb
H 0 (0.0%) 2 (6.4%) N.S.
R 2 (6.5%) 3 (9.7%)
W 4 (12.9%) 4 (12.8%)
B 1 (3.2%) 1 (3.2%)
S 11 (35.5%) 6 (19.5%)
O 13 (41.9%) 15 (48.4%)
Duration of diabetes (median and interquartile range) 16 (13e19) 15 (12e19) N.S.
Family history of DM 10 (32.3%) 14 (45.2%) N.S.
Smoking
Current 4 (12.9%) 11 (35.5%) N.S.
Never 26 (83.9%) 18 (58.1%)
Stopped 1 (3.2%) 2 (6.4%)
Previous structured education
Yes 30 (96.8%) 0 (0.0%) N.S.
No 1 (3.2%) 31 (100%)
Hypertensive
Yes 3 (10.3%) 7 (25%) N.S.
No 26 (89.7%) 21 (75%)
a P, primary school; M, middle school; H, high school; U, university degree.
b H, housewife; R, retired; W, white collar; B, blue collar; S, student, O, other.of educational and health objectives [21]. The new
curriculum designed with the patients included:
differences between type 1 and type 2 diabetes;
principles of nutrition, classification of nutrients,
composition of food and food exchanges: personal
habits and day-to-day management; how to embed
eating patterns into daily life, as tastes and habits
evolve over time; physical exercise: adaptation of
insulin dosage and daily activity; hypoglycaemia
and hyperglycaemia: why do they occur, how to
recognize and manage them, how to inform rela-
tives and friends; areas of insulin injection and
their rotation; retinopathy, neuropathy, microal-
buminuria and nephropathy: self-care, when and
how to screen; hypertension and cardio-vascular
aspects. The patients also requested that insulin,
glycated haemoglobin and day-to-day problems be
discussed whenever felt necessary. This patient-
centred approach [23] allowed us to re-designa new 9-visit programme. Six more visits were
delivered over the reminder of the 36 months’
observation reported in this paper, for a total of 15
group care sessions.
Procedure for group care
As is routine practice in our clinic, samples for
blood glucose, HbA1c and urine analysis, plus other
annual tests when applicable, were taken a few
days beforehand. Results were transcribed and
case notes checked by the doctor shortly before
group consultations.
Group visits were held every 2e3 months by
a doctor (PP) and a psychopaedagogist (MTr), who
acted as facilitators according to the methodolog-
ical principles of adult learning [24,25]. Sessions
were centred on hands-on activities, group work,
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and role playing, as well as group discussions
concerned with motivational aspects, acceptance
of diabetes, psychosocial problems and coping
strategies. In order to induce positive group
dynamics, patients were helped to identify and
share their problems and successes with the other
members and encouraged to report on their
personal experience, if they wished to [22e23].
Sessions were planned to last 40e50 min and were
followed by brief individual consultations with the
same doctor, to comment on laboratory results,
the previous group session, and yearly check-up or
emerging problems, if any.
Control patients continued to follow habitual
2e3 monthly one-to-one consultations in the di-
abetes clinic. They received individual education
sessions from the same psychopaedagogist in-
volved in group care, with special reference to
proper eating habits, home monitoring of blood
glucose, insulin administration and dose adjust-
ments, and preventing complications. Their knowl-
edge of diabetes was checked annually, when
screening for complications, and educational re-
inforcement offered accordingly. Control patients
were also offered 15 individual visits over the
3-year observation period.
Because of its approach, this study could not be
run as a double-blind trial. To minimize perfor-
mance bias, health operators were blinded to
which patients in the general diabetes clinic
served as controls. Results were adjusted for
schooling on multivariate analysis, to account for
possible selection bias resulting from differences
in schooling at baseline. Minimal dropout rate in
both treatment groups suggests negligible attrition
bias. Finally, outcomes were measured blindly
with respect to treatment group.
Evaluation of results
Body weight, fasting blood sugar (glucose-oxidase)
and HbA1c (HPLC) were measured at each visit.
Total and HDL cholesterol, triglyceride and micro-
albuminuria/creatininuria ratio, were measured
yearly during routine screenings for complications.
Hypoglycaemic episodes were assessed retrospec-
tively on the clinic case notes. Severe hypoglycae-
mia was defined as requiring third-party help, i.e.,
glucagons injection, i.v. glucose and/or hospital
admission.
Three questionnaires were administered at
baseline and after 3 years to measure:
(a) Quality of life, using the original version of the
DQOL questionnaire [6] translated into Italianand revalidated [26]. This questionnaire ex-
plores four primary scales: satisfaction, im-
pact, diabetes worry, and social/vocational
worry with 46 core items. Each item scores
between 5 (very dissatisfied) and 1 (very
satisfied). Hence, the total score ranges be-
tween 46 (higher quality of life) and 230 (lower
quality of life).
(b) Knowledge of T1DM, using a 57-item question-
naire developed and validated by the Educa-
tion Study Group of the Italian Society for
Diabetes (GISED) [27]. Correct answers scored
1 point and wrong answers scored 0.
(c) Health behaviours (‘‘Condotte di Riferimen-
to’’), with a purpose-built 30-item question-
naire for T1DM (CdReT1DM) that explores
simulated problem-solving ability. Questions
posed hypothetical situations using the ‘‘What
would you do if .’’ format to test ability to
identify underlying health problems and react
correctly. The situations proposed involved
coping with hypoglycaemia, glucagon injec-
tions, adapting insulin dosages to physical
activity and food ingestion, intercurrent dis-
ease, organizing holidays, informing relatives
and friends. Correct answers scored 1 point
and wrong ones scored 0. The questionnaire
was checked for internal consistency, by
Cronbach’s alpha coefficient [28], and for
internal validity by cluster analysis [29].
Economic analysis
Economic analysis was carried out from a quasi-
societal point of view with a costeutility ap-
proach, by calculating additional costs associated
with additional results of group care compared
with one-to-one visits.
Differential costs were calculated in Euros (V)
from the perspectives of both the Italian National
Health System (INHS) and the patients. All proce-
dures relevant to group and individual care were
directly timed and the relevant salaries of person-
nel involved calculated, assigning specific roles for
different group care sessions to a doctor, nurse,
dietician or psychopaedagogist. Based upon aver-
age salaries, costs to the INHS were estimated at V
0.85/min for physicians, V 0.32/min for registered
nurses, V 0.33/min for dieticians, and V 0.72/min
for a psychopaedagogist. Costs of insulin, diagnos-
tic materials and tests, and personnel time to
update clinical records were not included, because
they did not differ between group care and
controls. Differential costs of rooms and materials
were negligible, hence ignored. Direct costs borne
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opportunity of time spent in clinic, as obtained
from specific questionnaires administered to 27
patients on group care and 26 controls. The
questionnaires also included 2 items in which
patients were asked to indicate on 1e5 Likert
scales: (1) their level of perceived satisfaction and
(2) their opinion on the usefulness of the treat-
ment received. Patients on group care were also
asked if they would rather have individual visits
instead.
As previously done with T2DM [15e17], quality
of life was chosen as a non-clinical end-point
representative of the patients’ perceived well
being.
Statistical methods
Unless otherwise specified, results are expressed
as either meanG 1 standard deviation, if the
variable is approximately normally distributed, or
median and interquartile range (25the75th) if
skewed or non-continuous. The Statistical Package
for Social Sciences (SPSS Inc., Chicago, IL) was
used for calculations and to check the validity of
questionnaires.
Differences between baseline and year 3 values
within treatment groups are expressed as mean
and 95% CI. Changes in clinical, cognitive and
behavioural variables from baseline to year 3
between the two treatment groups were tested
by an analysis of covariance approach, adjusted
for baseline differences in the two groups.
A multivariate regression model was fitted,
using as dependent variable the calculated in-
crease/decrease from baseline to year 3 for each
cognitive and behavioural variable (DQOL, GISED,CdR) and for each clinical variable. Group care
(coded 0/1), baseline values of the dependent
variables and of the other cognitive or behavioural
variables plus baseline values of HbA1c, age,
duration of diabetes (coded in years) and schooling
(coded in a 2-level ordinal scale and introduced in
the model as dummy variable) were used as
independent variables.
Results
After 3 years, 1 patient on group care and 1 control
moved to other cities because of work commit-
ments and were lost to follow-up. Two more
control patients declined to participate in the final
visit and to fill in the questionnaires. In total, data
from 30 patients on group care and 28 controls
were available for final analysis. Patients on group
care missed only 20 out of 465 (31! 15) scheduled
appointments (4.3%), whereas controls missed 79
(16.7%), p! 0.001.
Univariate analysis showed that quality of life,
knowledge of diabetes and health behaviours
improved in the patients followed by group care
(p! 0.001, all). Among control patients, in con-
trast, quality of life worsened (p! 0.001) whereas
knowledge and behaviours remained unchanged
(Table 2). Cronbach’s coefficient for the CdRe
T1DM questionnaire was 0.59 at baseline and 0.64
three years later.
Multivariate analysis showed that the effect of
group care on quality of life, knowledge and health
behaviours was independent of age, duration
of diabetes or schooling. Being treated by group
care improved quality of life independently of
knowledge and behaviours (p! 0,001). Knowl-
edge, in turn, appeared to influence behavioursTable 2 Knowledge of diabetes, health behaviours and quality of life at baseline and year 3 in patients on group
care (nZ 30) and controls on individual care (nZ 28)
Baseline
(meanG SD)
3 years
(meanG SD)
Increase/decrease
(mean and 95% CI)
Difference
between group
care and
controls
(significance)
Knowledge
of diabetes
(GISED score)
Group care 44.34G 6.97 47.45G 6.03 3.10 (1.56 to 4.65)** p! 0.01
Controls 43.10G 6.28 43.34G 6.18 0.24 (0.32 to 0.80)
Health behaviours
(CdReT1DM score)
Group care 21.48G 3.18 25.28G 2.66 3.79 (2.61 to 4.98)** p! 0.001
Controls 22.38G 3.51 22.28G 3.35 0.10 (0.41 to 0.21)
Quality of life
(DQOL score)
Group care 79.37G 13.93 70.55G 12.20 8.82 (12.51 to 5.14)** p! 0.001
Controls 80.72G 11.52 84.06G 11.35 3.34 (2.38 to 430)**
** p! 0.001.
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on individual care (nZ 28)
Baseline
(meanG SD)
3 years
(meanG SD)
Increase/decrease
(mean and 95% CI)
Difference
group
careecontrols
(significance)
Body
weight (kg)
Group
care
71.91G 10.28 72.08G 10.42 0.17 (1.48 to 1.14) N.S.
Controls 70.35G 10.97 70.47G 13.45 0.12 (2.59 to 2.84)
Body mass
index (kg/m2)
Group
care
24.70G 3.37 24.74G 3.26 0.04 (0.42 to 0.50) N.S.
Controls 25.04G 3.78 25.09G 4.04 0.05 (0.91 to 1.01)
Fasting blood
glucose (mmol/L)
Group
care
9.61G 6.14 9.48G 4.78 0.13 (3.87 to 3.60) N.S.
Controls 12.25G 5.35 11.18G 5.45 1.06 (3.69 to 1.56)
HbA1c (percentage
of total haemoglobin)
Group
care
8.26G 0.15 7.88G 0.20 0.38 (0.83 to 0.07) N.S.
Controls 9.20G 1.64 8.79G 1.38 0.40 (0.85 to 0.04)
Insulin dosage
(Units/kg body weight)
Group
care
0.75G 0.15 0.75G 0.20 0.003 (0.052 to 0.059) N.S.
Controls 0.68G 0.27 0.72G 0.27 0.037 (0.034 to 0.11)
Total cholesterol
(mmol/L)
Group
care
4.89G 0.96 4.78G 0.98 0.09 (0.31 to 0.13) N.S.
Controls 5.08G 1.32 4.65G 1.16 0.42 (0.76 to 0.09)*
HDL cholesterol
(mmol/L)
Group
care
1.67G 0.42 1.79G 0.44 0.11 (0.01 to 0.22)* N.S.
Controls 1.62G 0.39 1.64G 0.35 0.02 (0.10 to 0.14)
Triglyceride
(mmol/L)
Group
care
0.73G 0.23 0.81G 0.30 0.08 (0.04 to 0.21) N.S.
Controls 1.16G 0.57 1.13G 0.61 0.03 (0.30 to 0.24)
Albuminuria/creatininuriaa Group
care
0.93 (0.53e2.5) 1.1 (0.52e2.13) e N.S.
Controls 1.0 (0.56e2.5) 0.91 (0.27e2.18) e
Foot ulcers
(never/past/active)
Group
care
30/0/0 29/1/0 e N.S.
Controls 28/0/0 25/3/0 e
*p! 0.05; **p! 0.001.
a Due to the non-normal distribution of the data, median and interquartile range (25the75th) are reported for this variable. For
the same reason the Wilcoxon signed rank test has been used to test the difference between baseline and 3 year value.independently of the effect of group care
(pZ 0.004), summing its effects to those of group
care.
HbA1c decreased, though not significantly so, in
both group and control patients. Total cholesterol
decreased in the controls (p! 0.05), while HDL
cholesterol increased in the patients on group care
(pZ 0.027). There were no significant modifica-
tions in the other clinical variables monitored
(Table 3). Only 1 patient on group care had
a glucagon-requiring episode of hypoglycaemia
and 4 more had one episode each that did not
require third-party assistance. Among controls,3 patients had 3, 2 and 1 episodes, respectively,
and 1 required admission for ketoacidosis.
Group care sessions had an average duration of
45.8G 4.6 min, followed by 7.5G 0.9 min for each
individual consultation. One-to-one control visits
required 19.0G 1.6 min. Overall, over 3 years,
INHS costs were V 177.79 per patient in group
sessionsCV 93.45 for the following individual
meeting with the doctor, totalling V 271.24.
Control visits cost the INHS V 120.15 per patient.
Patient transportation costs were V 526.95 for
either option. Patients estimated the coste
opportunity of their time in clinic at V 135.00
Group care in type 1 diabetes 299and V 49.50, totalling V 661.95 and 576.45 for
group and one-to-one care, respectively.
In total, direct costs per patient for group and
one-to-one care were V 933.19 and V 697.10,
respectively. The V 236.09 difference, divided by
the 12.16 differential DQOL score between group
and individual care, gives a costeutility ratio of
V 19.42 spent over 3 years for each point gained
in the quality of life scale. Taking into account
actual attendance rates, costs for group care
changed to V 907.88 and those of one-to-one
visits decreased to V 574.31 per patient actually
attending appointments. Assuming that INHS
resources saved were used efficiently for other
purposes, the gap would widen to V 333.57, or
V 27.43 per point gained in the quality of life
scale. In another sensitivity analysis, using a
smaller team composed of well-trained nurses
and dieticians reduced to V 12.83 the extra cost
spent per point gained in the quality of life scale.
There was no difference in the level of per-
ceived satisfaction for treatment between pa-
tients on group care (2.78G 0.58) and controls
(2.96G 0.66), but the former assigned a higher
score to the usefulness of group care (1.07G 0.27)
than those on individual care (2.00G 0.80),
p! 0.0001. One patient declared he would prefer
individual visits because group care clashed with
his timetable, whereas the other 26 interviewed
opted to continue group care, because they felt it
improved their knowledge and allowed them
to share their problems with similarly affected
people.
Discussion
This paper confirms that group care is a feasible
and cost-effective approach to delivering continu-
ing education within routine care to patients with
T1DM, similarly to what we previously showed in
patients with non-insulin-treated T2DM [17e19].
Also in T1DM, group care improved quality of life,
knowledge of diabetes and health behaviours with
acceptable additional costs, although the effects
on metabolic control were more evident on HDL
cholesterol than on HbA1c levels (Tables 2 and 3).
Differently from our experience with T2DM,
T1DM patients were involved from the start in
developing the education programme through
focus groups [18] held to define the topics to be
covered and their relative emphasis. Interestingly,
when focus groups were repeated after one full
cycle of sessions, the patients’ choices and inter-
ests [30,31] had changed, suggesting that a major
shift had occurred from a rather ‘‘academic’’approach to a vision based upon the patients’
own expectations, needs and goals [21]. Collabo-
rative alliance, mutual decision making, sustained
partnerships and shared responsibilities are the
tools that describe this patient-centred approach,
implying continuous resetting of individualized
goals and expectations [23]. These observations
confirm that formative evaluation can be used to
design education programmes to meet patients’
perceived needs [25].
The results suggest that diabetic adults acquire
new knowledge and behaviours, independently of
schooling or age, if exposed to procedures and
settings specifically tailored to their needs and
characteristics. Knowledge appeared to influence
behaviours independently of the effect of group
care, suggesting that our approach was not only
able to deliver new notions but also to further
motivate patients to put them into practice. In
contrast, patients followed by the traditional one-
to-one approach did not modify their knowledge or
ability to solve simulated daily problems. Selected
interventions that improve patients’ adherence
can be educational, affective or behavioural [32].
Education may take the form of individual instruc-
tion or group classes, it might be provided in writing
or through media like videotapes, computers or
access to special internet sites, but in any event the
key is providing a simple, clear message, hopefully
tailored to the needs of the individual, and verifying
that the message has been understood [33].
Quality of life improved directly as a result of
group care, independently of knowledge, health
behaviours, age, duration of diabetes, schooling or
clinical variables. Quality of life is influenced by
multifaceted factors, which are not necessarily
those involved in day-to-day self-management
[31,34], and is linked to self-perception and other
psychosocial factors including health-related be-
liefs, social support, coping style and personality
type, either directly or because they help in
buffering the negative effects of diabetes or its
management. Advantages of group over individual
care include emotional support from peers and
ability to use the experiences of others as a model.
Being part of a group, being understood by others
and understanding them, and being able to give
and receive help strengthens the sense of belong-
ing and enhances emotional well being. Previous
clinical and educational intervention studies sug-
gest that improving patients’ health status and
perceived ability to control their disease results in
better quality of life [34]. In contrast, quality of life
was reported to decrease with increasing duration
of diabetes [35,36], as it did in our control group,
though not all authors confirm this finding [37].
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style by providing guidance to eating, exercise and
healthy practices in general. Inducing conscious
health conducts, i.e., understanding why choices
have to be made, rather than passive behavioural
changes was the goal of our approach. Though
eating habits and physical activity were not
assessed directly, the results of the CdReT1DM
questionnaire (Table 2) suggest that they may have
improved. Further support to the notion that group
care induced lifestyle modification is provided by
the increased levels of HDL cholesterol [38e40],
similar to what we observed in T2DM [15e17].
HbA1c was not modified. Possibly, our educational
programme focused more on general lifestyle
issues and less on such specific skills as carbohy-
drate counting and fine adjusting of insulin dosage,
as practiced by other approaches that improved
HbA1c in the short term, also improving quality of
life at 1 year [41].
The additional costs required to improve the
quality of life scale would be considered negligible
by health economics standards [41]. The choice
of this surrogate indicator of costeutility was
made on the basis of our previous experience with
T2DM [16] and because of the impossibility of
translating our results in quality-adjusted life
years [41]. Although the programme in our setting
was run jointly by a doctor and a highly experi-
enced psychopaedagogist, personnel costs were
calculated on the assumption that, in other clinics,
nurses and dieticians would participate in group
sessions. Two types of sensitivity analysis were
undertaken to further assess the robustness of this
cost-effectiveness ratio, showing that: (1) since
patients on group care miss much less appoint-
ments, differential costs rise if one takes into
account the actual attendance rates, and (2)
a smaller team composed of well-trained nurses
and dieticians could reduce by 34% the extra cost
spent per point gained in quality of life. Either
way, these remain appealing economic results.
Finally, patients wholeheartedly endorsed
group care. Although both treatments elicited
the same degree of perceived satisfaction, group
care earned a higher usefulness score and nearly
all patients were unwilling to go back to one-to-
one consultations, the only exception being moti-
vated by timing problems.
It is often stated that new models should be
developed to empower patients and build strate-
gies that enable them to cope with chronic
diseases. It is also suggested that patient training
programmes should routinely aim at enhancing
beliefs in self-efficacy, because positive experien-
ces have already been reported in this area [42]and because pure, cognitive knowledge of illnesses
and their treatment bears limited significance to
everyday life. Our results suggest that group care
may represent one such model, in which education
merges with clinical care. Though alternative
approaches should be negotiated with the patients
to achieve more impact on metabolic control,
group dynamics and peer identification appear to
lead to more active coping behaviour and im-
proved quality of life.
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